Colon cancer: risk factors, early diagnosis, and treatment options

Un médico señala un modelo anatómico del colon para explicar el cáncer de colon, mientras una paciente yace en una camilla al fondo, siendo atendida por otro profesional de la salud.

Colon cancer is one of the most common types of cancer worldwide. With an increasing incidence, especially among people under the age of 50, it is essential to be informed about its symptoms, risk factors, prevention methods and treatment options.

What is colon cancer?

Colon cancer is a proliferation of cells that begins in the large intestine, also called the colon. It usually develops from adenomatous polyps that can become cancerous over time if left undetected. At this stage they can be removed by colonoscopy.

 

Symptoms of colon cancer

The symptoms of colon cancer depend largely on the location in the large intestine. Colon cancer that first develops in the early part of the colon, where the appendix and what is known as the right colon are located, is usually more indolent and is therefore diagnosed at more advanced stages.

In contrast, cancer located in the final part of the intestine, at the level of the sigmoid colon or rectum, usually gives symptoms earlier, such as bleeding or intestinal obstruction. Occasionally, there are also alterations in intestinal transit, such as the appearance of episodes of diarrhea or constipation. Most common symptoms:

Persistent change in bowel habits

Diarrhea, constipation or decreased stool diameter for several days.

Blood

Rectal bleeding, dark stools, or blood in the stool.

Persistent abdominal discomfort

Sensation of need to have a bowel movement that does not go away after a bowel movement, abdominal pain or cramping, or continued discomfort in the abdominal area, such as cramping, gas, or pain.

Weakness or fatigue

Feeling tired, weak, or exhausted.

Unexplained weight loss

Unexplained weight loss is another common symptom of colorectal cancer.

 

Causes and Risk Factors for Colon Cancer

Colon cancer is one of the most common tumors worldwide, accounting for 10% of all cancer cases. Although historically it has been diagnosed from the age of 50 years onwards, by 2024 a significant increase in the number of cases in people under 50 years of age is expected for the first time in history.

This significant increase in incidence among the very young has meant that the warning signs, previously relevant mainly for those over 50, must now also be monitored in very young patients.

Genetic and hereditary factors

Colon cancer can have a strong genetic component, with some hereditary syndromes significantly increasing the risk. One of the best known is Lynch syndrome, also called hereditary non-polyposis colorectal cancer (HNPCC). People with this syndrome are at high risk of developing colon cancer, often at a younger age than the general population.

Another important syndrome is familial adenomatous polyposis (FAP), an inherited condition in which numerous polyps develop in the colon and rectum during adolescence, leading to an almost inevitable risk of colon cancer if not properly treated.

Lifestyle factors

Lifestyle plays a crucial role in the risk of developing colon cancer. A diet rich in red and processed meats, as well as nitrites, is associated with an increased risk. Alcohol consumption and smoking are also important risk factors. In addition, lack of physical activity and sedentary lifestyle contribute to the development of any type of disease.

Maintaining a balanced diet, avoiding excessive alcohol and tobacco consumption, and regular physical activity are measures that can reduce the risk of colon cancer.

Age and medical history 

Advanced age is one of the most important risk factors for colon cancer, as most cases are diagnosed in people over the age of 50. However, with the increased incidence in people younger than 50 years, surveillance should begin earlier if risk factors are present.

Medical history is also crucial; having had adenomatous polyps or a personal or family history of colon cancer greatly increases the risk. It is essential that people with this history undergo regular screening to detect and treat any changes early.

 

Treatments for colon cancer

Surgery

  • Endoscopic resection: a technique used to remove adenomatous polyps or malignant tumors at an early stage.
  • Laparoscopic or robotic surgery: this minimally invasive technique allows tumors to be removed through small incisions, offering benefits such as faster recovery and less postoperative pain. Laparoscopic resections of the right and left colon, complete removal of the colon, rectal resections and even the entire colon and rectum can be performed.

Chemotherapy

Administered after surgery to eliminate any residual cancer cells, reducing the risk of recurrence.

Radiation therapy

Uses high-energy rays to destroy remaining cancer cells and may be used before or after surgery to shrink the tumor and reduce the risk of recurrence.

Targeted therapies

These treatments specifically target cancer cells. Examples include the use of monoclonal antibodies or cell signaling inhibitors.

Immunotherapy

Some patients may benefit from immunotherapy treatments if the tumor has certain mutations.

 

Prevention of colon cancer 

Due to the increasing incidence in those under 50 years of age, some countries have already lowered the starting age for the first screening colonoscopy to 45 years. Also, whenever there is a case in the first-degree family or risk factors, the first colonoscopy should be started at the age of 40.

Colon cancer is the only type of cancer that can be prevented by colonoscopy. If polyps are removed before they turn into cancer, the patient will never develop colon cancer. In other organs, such as the lung or breast, cancer appears without a similar window of opportunity. If a patient continues to have screening colonoscopies, it significantly reduces the chances of developing colon cancer.

 

Colon Cancer Mortality and Prognosis

The prognosis and survival of colon cancer can vary depending on several factors, such as the stage of the disease. 5-year survival rates for colon cancer, according to the American Cancer Society:

Localized: if diagnosed at an early stage, the survival rate is 91%.
Regional: when the cancer has spread externally from the colon or rectum to nearby structures or lymph nodes, the survival rate is 72%.

Metastatic: if the cancer has spread to distant parts of the body, such as the liver, lungs or distant lymph nodes, the survival rate is 13%, a rate that can increase considerably if the patient is a candidate for some surgical or systemic treatments or a combination of both.

 

Colon cancer is a preventable and treatable disease, especially when detected early. It is essential for people to be informed about risk factors, symptoms, and prevention and treatment options. Getting regular check-ups and adopting a healthy lifestyle are essential steps to reduce risk and improve prognosis if diagnosed.

IVOQA has become a referral center for colon and rectal cancer surgery and treatment. You can request a consultation with leading specialists in the approach to this pathology.

Dr. Rosa María Morera

Radiation Oncology

  • Specialist in Radiation Oncology.
  • Degree in Medicine and Surgery.  Faculty of Medicine, Complutense University of Madrid (2-8-1990).
  • Head of the Radiation Oncology Department, Hospital Universitario La Paz, Madrid.
  • Expert with university micro-credential mention in Physics, Technology and Protontherapy. King Juan Carlos University.
  • Higher University Course in Design and Management of Proton Therapy Centres. King Juan Carlos University.
  • XIX Programme of Senior Management in Health Institutions. IESE Business School. University of Navarra.
  • Master in Administration and Management of Health Services XXIV Edition (2013-2014). Pompeu Fabra University.
  • Doctoral Thesis Reading: ‘Radical thoracic irradiation and pulmonary functional study in patients with locally advanced non-small cell lung cancer. Systematic review and prospective case series’ . Qualification of outstanding ‘cum laude’.
  • Doctorate courses: Complutense University of Madrid (1995-1997).
  • She is a researcher in numerous clinical trials, publishing several national and international scientific articles.

Dr. Jose María Oliver

Breast radiology

  • Breast radiologist and specialist in cryoblation of breast lesions in the IVOQA Breast Unit.
  • Degree in Medicine and Surgery from the University of Navarra (1983-1989). Specialisation via MIR in Radiology. Number 289.
  • Specialist in radiology in several renowned hospitals, international reference and pioneer in the application of cryoablation to breast pathology in Spain.
  • Head of the Breast Radiology Section at the Hospital Universitario La Paz.
  • Member of the Spanish Society of Medical Radiology (SERAM) and the Spanish Society of Diagnostic Imaging (SEDIM).

Dr. Jesús Cañete Gómez

General and Digestive Surgery. Oncological Surgery

  • Graduate in Medicine and Surgery from the University of Seville (2000- 2006).
  • Specialist in colon and rectal cancer surgery using a minimally invasive approach.
  • Training in transanal rectal cancer treatment (TAMIS and TaTME).
    Training in minimally invasive surgery at Jackson Memorial Hospital (Miami).
  • Specialist in General Surgery at Viamed Fatima Hospital, Seville (currently).
  • Doctor of Medicine from the University of Seville (‘cum laude’).
  • Associate Professor at the University of Seville Founder of the surgical team Laparoscopic Surgery Seville – MISS (Minimally Invasive Surgical Solutions) – minimally invasive surgical techniques in scheduled and emergency surgery.
  • He has written numerous publications in journals and books and is a member of the Spanish Society of Obesity Surgery (SECO), as well as the Spanish Association of Surgeons (AEC) and the Andalusian Association of Surgeons (ASAC).

Dr. Juan José Segura Sampedro

General and digestive surgery. Oncological Surgery

  • Degree in Medicine and Surgery from the University of Seville. 2003-2009.
  • Specialist in peritoneal carinomatosis.
  • Doctor of Medicine from the University of Seville (‘cum laude’).
  • Oncological Surgeon in the Section of Peritoneal, Retroperitoneal and Soft Parts Oncological Surgery, Department of General and Digestive System Surgery, Hospital Universitario La Paz, Madrid.
  • Associate Professor of Surgery, Faculty of Medicine, University of the Balearic Islands, Palma de Mallorca.
  • 3IP in the Research Group in Advanced Oncological Surgery, m-Health and Innovation in Surgical Technology, Institute for Health Research of the Balearic Islands (IdISBa), Palma de Mallorca.
  • He has written numerous publications in journals and books and is a member of the Spanish Society of Surgical Oncology (SEOQ), the Spanish Society of Coloproctology (AECP), the Spanish Association of Surgeons (AEC), the European Society of Oncological Surgery (ESSO) and the Spanish Group of Peritoneal Oncological Surgery (GECOP).

Pablo Soto

Specialist in sports training for oncology patients

  • Higher Degree in Dietetics (2020-2022)
  • Treatment and rehabilitation of cancer patients

Dr. Gonzalez Larriba

Medical oncology

  • Professor of Medical Oncology at the Complutense University of Madrid
  • Head of the Medical Oncology Section of the Hospital Clínico San Carlos in possession of the European Certificate in Oncology
  • Recognition of 6 six-year research periods + 1 six-year period of knowledge transfer
  • Master in Oncology Services Management by the University of Alcala de Henares
  • Visiting Professor of Oncology at the University of Palermo (Italy)
  • Multiple stays in international centres (Memorial Sloan Kettering Cancer Center, Gustave Roussy Institute, University of Lyon, Princess Margaret Hospital in Toronto, University of Pittsburgh)
  • Maximum recognition of the Professional Career by the Regional Ministry of Health of the Community of Madrid
  • Director of the Master’s Degree in Genitourinary Tumours at the Complutense University of Madrid
  • Founder and member of the Board of Directors of the Spanish Lung Cancer Group, Spanish Genitourinary Tumour Group and Spanish Melanoma Group
  • Member of the Board of Directors of the Spanish Society of Medical Oncology
  • Miembro de la European Society of Medical Oncology, American Society of Clinical Oncology, International Association for the Study od Lung Cancer, etc.
  • Author of more than 300 scientific articles, 400 conference papers and 60 scientific books, as well as speaker in more than 400 conference papers

Francisco Flores

Physiotherapy

  • Graduate in physiotherapy. UEM.
  • Master’s degree in respiratory physiotherapy. UNIVERSITAT
  • ROVIRA i VIRGILI.
  • MASTER specialist in conservative and invasive physiotherapy of myofascial pain syndrome and fibromyalgia. UAH.
  • SPIROMETRIST by the ERS-SEPAR for the performance and interpretation of SPIROMETRY.
  • MASTER Specialist in intratissue percutaneous electrolysis treatments EPI.
  • Specialist in the use and application of the INDIBA ACTIV system.
  • MASTER Specialist in Biomechanical Analysis, Intervention and Treatment “Check yourMOtion”.
  • NATIONAL CLASSIFIER for athletes with cerebral palsy.
  • NATIONAL CLASSIFIER of athletics for people with physical disabilities.
  • RESEARCH PROJECT: “Respiratory physiotherapy as a treatment for ARVC in high performance athletes”.

Dr. Javier Heras Aznar

BREAST UNIT

  • Graduate in Medicine and Surgery from Universidad Autonoma de Madrid 1992.
  • Specialist via MIR in Family Medicine at Hospital Universitario Ramón y Cajal 1994-1996.
  • Specialist via MIR in OBSTETRICS AND GYNECOLOGY at Hospital Universitario Santa Cristina in Madrid 1997-2001.
  • Specialized in the last 27 years in Gynecological Oncology and Breast Pathology, both malignant and benign, with experience in Oncoplastic Surgery.
  • Specialization Course in Oncoplastic Breast Surgery 2015.
  • Coordinator of the Breast Unit and the Breast Tumors and Gynecology Oncology Committee in Hospital Universitario Infanta Sofía.
  • Main Author of the Breast Unit Accreditation Project (Hospital Universitario Infanta Sofía) 2019-2020.

Dr. Beatriz García-Conde

DIGESTIVE SYSTEM MEDICINE

  • Graduate in Medicine and Surgery.
  • MIR specialisation in Digestive System Medicine, Puerta de Hierro University Hospital in Majadahonda. Currently working at the 12 de Octubre University Hospital.
  • Specialist in capsule endoscopy and in diagnostic and therapeutic endoscopy: chromoendoscopy, colon cancer screening, digestive dilatations, PEG placement, endoluminal vacuum therapy (fistulas/leaks), polypectomy/mucosectomy.
  • She also a general digestive consultant with a Master’s Degree in Neurogastroenterology.

Dr. Micaela Riat Castro Zocchi

DIGESTIVE SYSTEM MEDICINE

  • Graduate in Medicine and Surgery.
  • MIR specialisation in Digestive System Medicine, Princesa Hospital (Madrid).
  • Clinical consultation. Diagnostic and therapeutic endoscopy: Chromoendoscopy, Colon Cancer Screening, Placement of digestive prosthesis (oesophagus, colon), Digestive dilatations, PEG Placement, Endoluminal Vacuum Therapy (fistulas/leaks), Polypectomy/mucosectomy. Experience in Bariatric Endoscopy: Intragastric balloon.

Dr. Diana Fresneda Cuesta

DIGESTIVE SYSTEM MEDICINE

  • Graduate in Medicine and Surgery.
  • MIR specialisation in Digestive System Medicine, Jiménez Díaz Foundation. (Madrid)
  • Clinical consultation. Specialist in Endoscopic Capsule and in Diagnostic and Therapeutic Endoscopy: Chromoendoscopy, Colon Cancer Screening, Ligation of Oesophagus Varices, Placement of digestive prosthesis (oesophagus, colon), Digestive dilatations, PEG Placement, Endoluminal Vacuum Therapy (fistulas/leaks), Polypectomy/mucosectomy. Experience in bariatric endoscopy: intragastric balloon, POSE method and Endo-sleeve with POSE system, etc.

Dr. Teresa Valdés Lacasa

DIGESTIVE SYSTEM MEDICINE

  • Graduate in Medicine and Surgery
  • MIR specialisation in Digestive System Medicine, 12 de Octubre University Hospital (Madrid). Advanced Endoscopy Fellowship (ERCP and digestive prostheses) at Ninewells Hospital (United Kingdom). 2020-2021.
  • Clinical consultation and abdominal ultrasound.
  • Specialist in pancreatico-biliary conditions and therapeutic endoscopy: ERCP, placement of digestive prostheses (oesophagus, duodenum, colon, biliary), digestive dilatations, placement of PEGs, endoluminal vacuum therapy (fistulas/leaks), polypectomy/mucosectomy.

Dr. Andrés J. del Pozo García, MD. PhD.

DUAL SPECIALISATION IN DIGESTIVE SYSTEM MEDICINE / FAMILY AND COMMUNITY MEDICINE

  • Graduate in Medicine and Surgery.
  • Dual specialised training (MIR) at the Princesa University Hospital (Madrid).
  • Specialist in Digestive System Medicine and Specialised in Family and Community Medicine
  • PhD in Medicine from the Autonomous University of Madrid. Cum Laude. 2020.
  • Member of S.E.P.D, S.E.E.D., A.E.G, E.S.G.E, AESPANC, Board Member of GETTEMO; Consultant of Apollo Endosurgery in 2021.

Dr. José María Abadal Villayandre

SPECIALIST IN VASCULAR INTERVENTIONAL RADIOLOGY

  • Graduate in Medicine and Surgery from Navarra University.
  • MIR specialisation in Radiology, Radiodiagnosis at Gregorio Marañón University Hospital.
  • PhD in Radiodiagnosis from the Complutense University of Madrid. Cum Laude Doctoral Thesis.
  • Specialist in Vascular Interventional Radiology, accreditation from the Spanish Society of Interventional Radiology.
  • European Board Interventional Radiology (EBIR) Health Sciences) at Alfonso X el Sabio University. 2010-2014.
  • Medical Director of the “Centro de Radiología y Diagnóstico por Imagen”.
  • Scientific and research activity with numerous publications and research studies.
  • Director and professor of Interventional Vascular Radiology at the I-XI Endo-school. Teaching activity.
  • Member of SERAM (Spanish Society of Medical Radiology), CIRSE (Cardiovascular Interventional Radiology Society Europe), and Secretary of SERVEI (Spanish Society of Interventional Vascular Radiology).

Belén Pérez Peiro. Psychologist

SPECIALIST IN PSYCHO-ONCOLOGY

  • Graduate in Psychology
  • Clinical psychologist, Gregorio Marañón University General Hospital, Psycho-oncology, Gynaecological Psychology, Neuropsychology, Detoxification and Out-patient Hospital, inflammatory bowel disease and teenagers.
  • Clinical activity at the Niño Jesús Children’s University Hospital, Psychiatric and Eating Disorder Units.
  • Expert qualification in Psychosomatic Medicine and Health Psychology.
  • Expert qualification in Psychopathology and Psychiatry from the Spanish Society of Psychosomatic Medicine and Medical Psychology.
  • Specialist qualification in Psychotherapy and projective techniques, both of which are recognised by the Madrid Official Association of Psychologists.

Dr. Ana María Moreno

SPECIALIST IN INTERNAL MEDICINE AND NUTRITIONAL PREHABILITATION

  • Graduate in Medicine and Surgery. 1986– 1992.
  • Extraordinary Graduation Award. 1992.
  • MIR specialisation in Internal Medicine. Number 283.
  • Master’s Degree in Palliative Care from Valladolid University. 2011.
  • University Master’s Degree in Advanced Chronic Nursing and palliative care from Antonio de Nebrija University. 2017.
  • PhD Courses 1993.
  • Extensive professional career in many renowned hospitals.
  • Head of Internal Medicine Services at Viamed Santa Elena (Madrid). September 2021 – Present.
  • Teaching and research work.
  • Numerous publications and papers. Participation in courses and seminars.